Estrogen and COVID-19: friend or foe?
- PMID: 33794291
- PMCID: PMC8005378
- DOI: 10.1016/j.annonc.2021.03.201
Estrogen and COVID-19: friend or foe?
Conflict of interest statement
Disclosure The authors have declared no conflicts of interest.
Comment on
-
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy.Ann Oncol. 2021 May;32(5):676-677. doi: 10.1016/j.annonc.2021.01.069. Epub 2021 Jan 29. Ann Oncol. 2021. PMID: 33524477 Free PMC article. No abstract available.
References
-
- EpiCentro COVID-19 integrated surveillance: key national data. https://www.epicentro.iss.it/coronavirus/sars-cov-2-sorveglianza-dati Available at: Accessed February 12, 2021.
-
- Riggs B.L., Hartmann L.C. Selective estrogen-receptor modulators-mechanisms of action and application to clinical practice. N Engl J Med. 2003;348(7):618–629. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
